MYC and lymphoma: Syngeneic NK cells (CD3−NKp46+) from normal mice when adoptively-transferred into T-lymphoma-bearing NSG recipients at the time of MYC inactivation delayed lymphoma recurrence and prolonged OS (Fig. 7e–g) when compared to vehicle-treated controls.